Abstract
Introduction

18
Organ-on-a-chip is an emerging technology addressed to reduce animal testing and accelerate clinical 
19
To reproduce more than one tissue-tissue interface in a single device, we have developed a novel 20 microfluidic device where cells are arranged in parallel compartments but are highly interconnected 21 through a grid of microgrooves under the cells (Fig. 1 
20
Materials and methods
21
Microfluidic device design
22
The microfluidic device is structured in side-to-side compartments that are interconnected through a 23 grid of microgrooves. It comprises a PDMS slab containing 7 compartments and a glass chip with 24 microgrooves and electrodes for TEER measurements and recording of extracellular field potential.
25
The compartments are 500 µm in width, 230 µm in height, and spaced by 50 µm. Two arrays of 
21
Fluorescence images were analyzed with ImageJ software to quantify the intensity in the compartments. numerical study according to our previous work 18 is provided in the ESI (Fig. S5) . Normalizing the TEER
16
to the area of the electrodes does not take into account that the effective area through which the 17 current passes the cell layer depends on the TEER value.
18
Electrical impedance between the two electrodes was acquired with an impedance analyzer 36 and current by 10 mVp and 10 µAp, respectively. The resistance at middle frequencies (Fig. 3C) 
16
After seeding, cells were incubated under static conditions for 1.5-3 h to ensure cell attachment.
17
Then, the cells were perfused with their respective culture media at a rate of 0.1 mL min -1 for 3 days.
18
For the case of the neuronal cells, the medium was only flowed through the central compartment to 
10
Results and discussion
11
We validated the developed microfluidic device with a co-culture of primary HREC, the SH-SY5Y human 12 neuroblastoma cell line, and the ARPE-19 human retinal pigment epithelial cell line. Cells were 13 cultured at confluence, and maintained with a continuous supply of culture medium for 3 days (Fig. 4 ).
14
The formation of endothelial and epithelial barriers was assessed by their permeability to dextran (Fig. 6D ).
22
Transepithelial electrical resistance
23
To validate the TEER measurement system that uses two straight parallel electrodes at the bottom of 24 the microgrooves, we compared the resistance measured using this two basal electrodes to the 25 conventional TEER measurement using electrodes in apical and basal sides. For that, the PDMS slab of 26 the device was perforated as in Fig. 7A to introduce an additional Pt wire electrode in the apical side.
27
In Fig. 7B 
24
R µg (40 k, details are provided in Fig. S2 ) is much higher than the maximum measured resistance 25 (R < 6 k). Thus, the measured resistance (R) was mainly contributed by the TEER in series with R s .
26
Although the measurement system is suitable to measure a large range of TEER values neglecting R µg ,
27
it would be possible to incorporate the calculated R µg value when measuring high TEER values.
28
In Fig. 8A , the impedance spectra measured with and without a monolayer (ARPE-19 or HREC) 1 covering the grid are shown. In the Bode representation, the change that causes the cell barrier in the 2 impedance spectra is clearly observed. Herein, the rise in resistance in the middle frequencies is 3 associated with the increase of the TEER value. The time course of R is shown in Fig. 8B . After 1 h, cells 4
were successfully attached to the microgroove grid, and during the first day, the R increased 5 supposedly due to cell spreading until it reached a plateau. This coincided with the monolayer 6 formation observed under the microscope. 
18
As a proof-of-concept, we used the fabricated device to mimic the structure of the BRB by co- 
23
In conclusion, the presented multi-compartment microfluidic device with integrated 24 electrophysiological monitoring electrodes will permit us to make more accurate measurements of cell 25 behavior than can be obtained in the currently static models. Thus, it can be envisaged as a promising 26 new approach for recapitulating multi-barrier models. In particular, it will facilitate the study of retinal diseases affecting BRB integrity and neurovascular coupling such as DR, which remains the leading 1 cause of blindness in working-age individuals in the western world.
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